Revisional bariatric surgery is more effective for improving obesity-related co-morbidities than it is for reinducing major weight loss

Daniel McKenna, Don Selzer, Michael Burchett, Jennifer Choi, Samer Mattar

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Results: Twenty-two patients with a history of RYGB and 56 with a history of VBG were identified. Following the revisional procedure, the RYGB group experienced 35.8% excess weight loss (%EWL) and a 31.8% morbidity rate. For the VBG group, patients experienced a 46.2% %EWL from their weight before the revisional operation with a 51.8% morbidity rate. Co-morbidity remission rate was excellent. Diabetes (VBG:100%, RYGB: 85.7%), gastroesophageal reflux disease (VBG: 94.4%, RYGB: 80%), and hypertension (VBG: 74.2%, RYGB:60%) demonstrated significant improvement.

Background: Patients having previous bariatric surgery are at risk for weight regain and return of co-morbidities. If an anatomic basis for the failure is identified, many surgeons advocate revision or conversion to a Roux-en-Y gastric bypass. The aim of this study was to determine whether revisional bariatric surgery leads to sufficient weight loss and co-morbidity remission.

Conclusion: Revision of a failed RYGB or conversion of a VBG to a RYGB provides less weight loss and a higher complication rate than primary RYGB but provides an excellent opportunity for co-morbidity remission. (Surg Obes Relat Dis 2014;10:654660.).

Patients and Methods: From 2005-2012, patients undergoing revision were entered into a prospectively maintained database. Perioperative outcomes, including complications, weight loss, and co-morbidity remission, were examined for all patients with a history of a previous vertical banded gastroplasty (VBG) or Roux-en-Y gastric bypass (RYGB).

Original languageEnglish (US)
Pages (from-to)654-660
Number of pages7
JournalSurgery for Obesity and Related Diseases
Volume10
Issue number4
DOIs
StatePublished - Jul 1 2014
Externally publishedYes

Fingerprint

Bariatric Surgery
Gastric Bypass
Gastroplasty
Weight Loss
Obesity
Morbidity
Weights and Measures
Gastroesophageal Reflux
Databases
Hypertension

Keywords

  • Bariatric surgery
  • Co-morbidity remission
  • Revision
  • Weight regain

ASJC Scopus subject areas

  • Surgery
  • Medicine(all)

Cite this

Revisional bariatric surgery is more effective for improving obesity-related co-morbidities than it is for reinducing major weight loss. / McKenna, Daniel; Selzer, Don; Burchett, Michael; Choi, Jennifer; Mattar, Samer.

In: Surgery for Obesity and Related Diseases, Vol. 10, No. 4, 01.07.2014, p. 654-660.

Research output: Contribution to journalArticle

McKenna, Daniel ; Selzer, Don ; Burchett, Michael ; Choi, Jennifer ; Mattar, Samer. / Revisional bariatric surgery is more effective for improving obesity-related co-morbidities than it is for reinducing major weight loss. In: Surgery for Obesity and Related Diseases. 2014 ; Vol. 10, No. 4. pp. 654-660.
@article{88a7d8ea4625417b89083076692f2f7c,
title = "Revisional bariatric surgery is more effective for improving obesity-related co-morbidities than it is for reinducing major weight loss",
abstract = "Results: Twenty-two patients with a history of RYGB and 56 with a history of VBG were identified. Following the revisional procedure, the RYGB group experienced 35.8{\%} excess weight loss ({\%}EWL) and a 31.8{\%} morbidity rate. For the VBG group, patients experienced a 46.2{\%} {\%}EWL from their weight before the revisional operation with a 51.8{\%} morbidity rate. Co-morbidity remission rate was excellent. Diabetes (VBG:100{\%}, RYGB: 85.7{\%}), gastroesophageal reflux disease (VBG: 94.4{\%}, RYGB: 80{\%}), and hypertension (VBG: 74.2{\%}, RYGB:60{\%}) demonstrated significant improvement.Background: Patients having previous bariatric surgery are at risk for weight regain and return of co-morbidities. If an anatomic basis for the failure is identified, many surgeons advocate revision or conversion to a Roux-en-Y gastric bypass. The aim of this study was to determine whether revisional bariatric surgery leads to sufficient weight loss and co-morbidity remission.Conclusion: Revision of a failed RYGB or conversion of a VBG to a RYGB provides less weight loss and a higher complication rate than primary RYGB but provides an excellent opportunity for co-morbidity remission. (Surg Obes Relat Dis 2014;10:654660.).Patients and Methods: From 2005-2012, patients undergoing revision were entered into a prospectively maintained database. Perioperative outcomes, including complications, weight loss, and co-morbidity remission, were examined for all patients with a history of a previous vertical banded gastroplasty (VBG) or Roux-en-Y gastric bypass (RYGB).",
keywords = "Bariatric surgery, Co-morbidity remission, Revision, Weight regain",
author = "Daniel McKenna and Don Selzer and Michael Burchett and Jennifer Choi and Samer Mattar",
year = "2014",
month = "7",
day = "1",
doi = "10.1016/j.soard.2013.12.007",
language = "English (US)",
volume = "10",
pages = "654--660",
journal = "Surgery for Obesity and Related Diseases",
issn = "1550-7289",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Revisional bariatric surgery is more effective for improving obesity-related co-morbidities than it is for reinducing major weight loss

AU - McKenna, Daniel

AU - Selzer, Don

AU - Burchett, Michael

AU - Choi, Jennifer

AU - Mattar, Samer

PY - 2014/7/1

Y1 - 2014/7/1

N2 - Results: Twenty-two patients with a history of RYGB and 56 with a history of VBG were identified. Following the revisional procedure, the RYGB group experienced 35.8% excess weight loss (%EWL) and a 31.8% morbidity rate. For the VBG group, patients experienced a 46.2% %EWL from their weight before the revisional operation with a 51.8% morbidity rate. Co-morbidity remission rate was excellent. Diabetes (VBG:100%, RYGB: 85.7%), gastroesophageal reflux disease (VBG: 94.4%, RYGB: 80%), and hypertension (VBG: 74.2%, RYGB:60%) demonstrated significant improvement.Background: Patients having previous bariatric surgery are at risk for weight regain and return of co-morbidities. If an anatomic basis for the failure is identified, many surgeons advocate revision or conversion to a Roux-en-Y gastric bypass. The aim of this study was to determine whether revisional bariatric surgery leads to sufficient weight loss and co-morbidity remission.Conclusion: Revision of a failed RYGB or conversion of a VBG to a RYGB provides less weight loss and a higher complication rate than primary RYGB but provides an excellent opportunity for co-morbidity remission. (Surg Obes Relat Dis 2014;10:654660.).Patients and Methods: From 2005-2012, patients undergoing revision were entered into a prospectively maintained database. Perioperative outcomes, including complications, weight loss, and co-morbidity remission, were examined for all patients with a history of a previous vertical banded gastroplasty (VBG) or Roux-en-Y gastric bypass (RYGB).

AB - Results: Twenty-two patients with a history of RYGB and 56 with a history of VBG were identified. Following the revisional procedure, the RYGB group experienced 35.8% excess weight loss (%EWL) and a 31.8% morbidity rate. For the VBG group, patients experienced a 46.2% %EWL from their weight before the revisional operation with a 51.8% morbidity rate. Co-morbidity remission rate was excellent. Diabetes (VBG:100%, RYGB: 85.7%), gastroesophageal reflux disease (VBG: 94.4%, RYGB: 80%), and hypertension (VBG: 74.2%, RYGB:60%) demonstrated significant improvement.Background: Patients having previous bariatric surgery are at risk for weight regain and return of co-morbidities. If an anatomic basis for the failure is identified, many surgeons advocate revision or conversion to a Roux-en-Y gastric bypass. The aim of this study was to determine whether revisional bariatric surgery leads to sufficient weight loss and co-morbidity remission.Conclusion: Revision of a failed RYGB or conversion of a VBG to a RYGB provides less weight loss and a higher complication rate than primary RYGB but provides an excellent opportunity for co-morbidity remission. (Surg Obes Relat Dis 2014;10:654660.).Patients and Methods: From 2005-2012, patients undergoing revision were entered into a prospectively maintained database. Perioperative outcomes, including complications, weight loss, and co-morbidity remission, were examined for all patients with a history of a previous vertical banded gastroplasty (VBG) or Roux-en-Y gastric bypass (RYGB).

KW - Bariatric surgery

KW - Co-morbidity remission

KW - Revision

KW - Weight regain

UR - http://www.scopus.com/inward/record.url?scp=84908103661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908103661&partnerID=8YFLogxK

U2 - 10.1016/j.soard.2013.12.007

DO - 10.1016/j.soard.2013.12.007

M3 - Article

VL - 10

SP - 654

EP - 660

JO - Surgery for Obesity and Related Diseases

JF - Surgery for Obesity and Related Diseases

SN - 1550-7289

IS - 4

ER -